Literature DB >> 10432396

Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis.

V Ophascharoensuk1, C M Giachelli, K Gordon, J Hughes, R Pichler, P Brown, L Liaw, R Schmidt, S J Shankland, C E Alpers, W G Couser, R J Johnson.   

Abstract

BACKGROUND: Osteopontin is a macrophage adhesive protein that is expressed by renal tubules in tubulointerstitial disease.
METHODS: To investigate the function of OPN, we induced tubulointerstitial disease in OPN null mutant (OPN-/-) and wild-type (OPN+/+) mice by unilateral ureteral ligation. Tissue was analyzed for macrophages (ED-1), types I and IV collagen deposition, TGF-beta expression, and for tubular and interstitial cell apoptosis.
RESULTS: Obstructed kidneys from both OPN-/- and OPN+/+ mice developed hydronephrosis, tubular atrophy, interstitial inflammation and fibrosis. OPN was absent in OPN-/- kidneys but was increased in obstructed OPN+/+ kidneys. Macrophage influx, measured by computer-assisted quantitative immunostaining, was less in OPN-/- mice compared to OPN+/+ mice at day 4 (threefold, P < 0.02), day 7 (fivefold, P < 0.02), but not at day 14. Interstitial deposition of types I and IV collagen were also two- to fourfold less in obstructed OPN-/- kidneys (P < 0.02). There was also a reduction of TGF-beta mRNA expression in the interstitium at day 7 (by in situ hybridization) and a near significant 34% reduction in cortical TGF-beta activity (P = 0.06) compared to obstructed OPN+/+ kidneys at day 14. Obstructed kidneys from OPN-/- mice also had more interstitial and tubular apoptotic cells (TUNEL assay) compared to obstructed OPN+/+ mice at all time points. The ability of OPN to act as a cell survival factor was also documented by showing that the apoptosis of serum-starved NRK52E renal epithelial cells was markedly enhanced in the presence of neutralizing anti-OPN antibody.
CONCLUSION: OPN mediates early interstitial macrophage influx and interstitial fibrosis in unilateral ureteral obstruction. OPN may also function as a survival factor for renal tubulointerstitial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432396     DOI: 10.1046/j.1523-1755.1999.00580.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  64 in total

1.  Unexpected news in renal fibrosis.

Authors:  Juan A Oliver
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification.

Authors:  Susan A Steitz; Mei Y Speer; Marc D McKee; Lucy Liaw; Manuela Almeida; Hsueh Yang; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice.

Authors:  Masahito Hirose; Keiichi Tozawa; Atsushi Okada; Shuzo Hamamoto; Yuji Higashibata; Bin Gao; Yutaro Hayashi; Hideo Shimizu; Yasue Kubota; Takahiro Yasui; Kenjiro Kohri
Journal:  Urol Res       Date:  2011-08-11

Review 4.  Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.

Authors:  James D Bryers; Cecilia M Giachelli; Buddy D Ratner
Journal:  Biotechnol Bioeng       Date:  2012-05-24       Impact factor: 4.530

5.  Inhibition of osteopontin reduces liver metastasis of human pancreatic cancer xenografts injected into the spleen in a mouse model.

Authors:  Keisuke Ohno; Hidefumi Nishimori; Takahiro Yasoshima; Kenjiro Kamiguchi; Fumitake Hata; Rika Fukui; Koichi Okuya; Yasutoshi Kimura; Ryuichi Denno; Shigeyuki Kon; Toshimitsu Uede; Noriyuki Sato; Koichi Hirata
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

6.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

Authors:  Jeremy S Duffield; Stuart J Forbes; Christothea M Constandinou; Spike Clay; Marina Partolina; Srilatha Vuthoori; Shengji Wu; Richard Lang; John P Iredale
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice.

Authors:  Dennis Bruemmer; Alan R Collins; Grace Noh; Wei Wang; Mary Territo; Sarah Arias-Magallona; Michael C Fishbein; Florian Blaschke; Ulrich Kintscher; Kristof Graf; Ronald E Law; Willa A Hsueh
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

8.  Gene expression changes during the development of acute lung injury: role of transforming growth factor beta.

Authors:  Scott C Wesselkamper; Lisa M Case; Lisa N Henning; Michael T Borchers; Jay W Tichelaar; John M Mason; Nadine Dragin; Mario Medvedovic; Maureen A Sartor; Craig R Tomlinson; George D Leikauf
Journal:  Am J Respir Crit Care Med       Date:  2005-08-11       Impact factor: 21.405

Review 9.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

10.  Osteopontin is not critical for otoconia formation or balance function.

Authors:  Xing Zhao; Sherri M Jones; Wallace B Thoreson; Yunxia Wang Lundberg
Journal:  J Assoc Res Otolaryngol       Date:  2008-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.